MYGN Stock Quote Price and Forecast | CNN

MYGN

Myriad Genetics, Inc.

Key terms

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Mar 22 5:23am ET Myriad Genetics issued patent for MRD by TipRanks Mar 20 4:20pm ET Myriad Genetics announces patent granted for SneakPeek Snap device by TipRanks Mar 06 7:36am ET Piper Sandler Sticks to Their Hold Rating for Myriad Genetics (MYGN) by TipRanks Mar 01 1:03am ET Myriad Genetics: Hold Rating Amidst Growth and Market Uncertainty by TipRanks Feb 28 9:16am ET Myriad Genetics price target raised to $28 from $25 at Raymond James by TipRanks Feb 28 7:32am ET Piper Sandler Reaffirms Their Hold Rating on Myriad Genetics (MYGN) by TipRanks Feb 28 7:23am ET Myriad Genetics price target raised to $26 from $23 at TD Cowen by TipRanks Feb 28 6:58am ET Myriad Genetics price target raised to $17 from $14 at JPMorgan by TipRanks Feb 28 6:57am ET Myriad Genetics: A Sell Rating Amidst Profitability and Growth Concerns by TipRanks Feb 27 9:55pm ET Myriad Genetics: Hold Rating Maintained Amid Balanced Performance and Cautious Outlook by TipRanks Feb 27 4:58pm ET Myriad Genetics sees FY24 adjusted EPS 0c-5c, consensus (1c) by TipRanks Feb 27 9:16am ET Myriad Genetics, NCCHE collaborate on SCRUM-MONSTAR-SCREEN-3 study by TipRanks Feb 12 4:25pm ET Myriad Genetics management to meet with BTIG by TipRanks Feb 12 4:55am ET Myriad Genetics management to meet with BTIG by TipRanks Feb 08 7:39am ET Piper Sandler Reaffirms Their Hold Rating on Myriad Genetics (MYGN) by TipRanks Feb 05 7:50am ET Myriad Genetics management to meet with BTIG by TipRanks Feb 01 9:28am ET Myriad Genetics completes asset acquisition from Intermountain Health by TipRanks Jan 30 5:01pm ET Myriad Genetics names George Daneker as Chief Clinical Officer of Oncology by TipRanks Jan 18 6:12pm ET Myriad Genetics signs agreement to acquire certain assets from Intermountain by TipRanks Jan 08 8:28am ET Mesa Labs appoints Mark Capone to board of directors by TipRanks

No recent press releases are available for MYGN

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.

Scott Olson/Getty Images

Trump’s stock tumbles again after Truth Social announces it’s getting into streaming

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images

Samuel Corum/Bloomberg/Getty Images

Geopolitical strife is roiling Wall Street. Here’s what investors are watching

Donald Trump might no longer own a majority of TMTG after a new public share offering.

Joe Raedle/Getty Images

Trump stock tanks after announcing massive share sale

1040 US Individual Income Tax Return Form

Nora Carol Photography/Moment RF/Getty Images

Three ways investors can minimize their tax payments